AKAO stock news

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on April 22) BIONDVAX PHARMA/S ADR (NASDAQ: BVXV ) Eidos Therapeutics Inc, (NASDAQ: EIDX ) Down In The Dumps (Biotech stocks hitting 52-week lows on April 22) Achaogen Inc (NASDAQ: AKAO ) Arbutus Biopharma Corp (NASDAQ: ABUS ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Zafgen Inc (NASDAQ: ZFGN ) Stock In Focus Novartis Reports Strong Quarterly Results, Raises FY19 Core Operating Income Guidance Novartis AG (NYSE: NVS ) reported strong first-quarter results, with 2 percent net sales growth, thanks to 11 percent volume growth mainly from Cosentyx, Entresto, Lutathera, Promacta and Kisqali. Core operating income climbed 9 percent. The company expects net sales for 2019 to grow in mid-single digit in constant currency, with innovative medicines growing in mid-single digits and Sandoz generic business likely showing flat growth. Read more
Achaogen (AKAO) files for bankruptcy in a district court. Shares slump 65% on the announcement. Read more
Biopharmaceutical company Achaogen has filed for bankruptcy, seeking a buyer to take over its efforts to find a drug that will fight “superbug” infections, or bacteria that resist existing remedies. Read more

Achaogen stock halted for news pending

10:57am, Monday, 15'th Apr 2019
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. Read more
Checking up on some historical performance on shares of Achaogen, Inc. (NASDAQ:AKAO), we can see that the stock price performance for the last week is -15.17%. If we scroll back to the full year readi Read more
Achaogen Inc. (NASDAQ:AKAO) and Krystal Biotech Inc. (NASDAQ:KRYS) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as divid Read more
Sienna Biopharmaceuticals Inc. (NASDAQ:SNNA) and Achaogen Inc. (NASDAQ:AKAO) compete with each other in the Biotechnology sector. We will analyze and contrast their risk, analyst recommendations, prof Read more
Achaogen Inc. (NASDAQ:AKAO) and ContraFect Corporation (NASDAQ:CFRX), both competing one another are Biotechnology companies. We will compare their profitability, analyst recommendations, risk, divide Read more
Achaogen Inc. (NASDAQ:AKAO) and Codexis Inc. (NASDAQ:CDXS) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as dividends, an Read more
As Biotechnology companies, Protagonist Therapeutics Inc. (NASDAQ:PTGX) and Achaogen Inc. (NASDAQ:AKAO) are our subject to compare. And more specifically their analyst recommendations, profitability, Read more
We will be comparing the differences between Editas Medicine Inc. (NASDAQ:EDIT) and Achaogen Inc. (NASDAQ:AKAO) as far as risk, analyst recommendations, Read more
Investors may be diving into the latest company earnings reports trying to scope out some quality stocks to add to the portfolio. Nobody knows for sure which way overall market momentum will sway as w Read more
Achaogen Inc (AKAO)’s moving averages reveal that the Tenkan line of the shares are below the Kijun-Sen line, indicating potential downward momentum building in the bearish chart. Achaogen Inc moved Read more
Orgenesis Inc. (NASDAQ:ORGS) and Achaogen Inc. (NASDAQ:AKAO) have been rivals in the Biotechnology for quite some time. Below is a review of each business Read more

Proudly made at

ROCKIT